Example: Heart Attack

Search clinical trials for: Linezolid

Total 153 results

NCT03898635

Recruiting

Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis

Conditions: Tuberculous Meningitis
NCT03537495

Not yet recruiting

Pharmacokinetic Study of Linezolid for TB Meningitis

Conditions: Tuberculosis, Meningeal; Linezolid
NCT01224626

Completed

Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)

Conditions: Vancomycin Resistance Enterococcus Faecium
NCT03747497

Completed

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Conditions: Skin Diseases, Bacterial; Gram-Positive Bacterial Infections
NCT03841721

Unknown status

Linezolid in Healthy Volunteers

Conditions: Healthy
NCT01055769

Completed

Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects

Conditions: Healthy Volunteers
NCT02269319

Completed

MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Conditions: Bacterial Infections
NCT02877927

Completed

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Conditions: Bacterial Infections; Skin Structures and Soft Tissue Infections
NCT04531332

Active, not recruiting

Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Community-Acquired and Nosocomial Pneumonia

Conditions: Pneumonia
NCT02378480

Completed

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Conditions: Bacterial Infections; Skin Structures and Soft Tissue Infections
NCT01200654

Completed

Population Pharmacokinetics of Linezolid

Conditions: Methicillin-Resistant Staphylococcus AureuS
NCT03405064

Completed

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Conditions: Acute Bacterial Skin and Skin Structure Infections
NCT01805284

Unknown status

Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia

Conditions: Pneumonia
NCT02019420

Completed

Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)

Conditions: Pneumonia
NCT02778828

Completed

Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis

Conditions: Tuberculosis
NCT01561469

Completed

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

Conditions: Methicillin-Resistant Staphylococcus Aureus (MRSA); Hospital-Acquired Pneumonia
NCT00625703

Completed

Pharmacokinetics of Linezolid in Children With Cystic Fibrosis

Conditions: Cystic Fibrosis
NCT00666276

Completed

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

Conditions: Staphylococcal Infections
NCT00727844

Completed

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Conditions: Pulmonary Tuberculosis; Multidrug Resistant Tuberculosis; Extensively Drug Resistant Tuberculosis
NCT00359632

Terminated

Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater

Conditions: Optic Nerve Diseases
NCT01170221

Completed

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Conditions: Skin and Subcutaneous Tissue Bacterial Infections
NCT02087566

Completed

Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)

Conditions: Renal Failure; Impaired Renal Function
NCT00811980

Completed

The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents

Conditions: Sepsis
NCT01421511

Completed

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Conditions: Skin and Subcutaneous Tissue Bacterial Infections
NCT01128530

Completed

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

Conditions: Complicated Skin and Skin Structure Infections